Hiroki Ideguchi
Compliance Officer chez ASAHI KASEI CORPORATION
Profil
Mr. Hiroki Ideguchi is a Director & Executive Officer-General Affairs at Asahi Kasei Corp.
and an Executive Officer at Asahi Kasei Pharma Corp.
He is on the Board of Directors at Asahi Kasei Corp.
Postes actifs de Hiroki Ideguchi
Sociétés | Poste | Début |
---|---|---|
ASAHI KASEI CORPORATION | Compliance Officer | 01/04/2022 |
Asahi Kasei Pharma Corp.
Asahi Kasei Pharma Corp. Investment ManagersFinance Part of Asahi Kasei Corp., Asahi Kasei Pharma Corp. is a pharmaceutical and diagnostic company based in Tokyo, Japan. Asahi Kasei Pharma operates in the healthcare business unit of the Asahi Kasei Group, with a mission to sincerely care for each individual life and solve their unmet medical needs with a wealth of ideas and solid science. Asahi Kasei Corp. is a US $20 billion Japanese technology company that provides innovative, science-based solutions to a diverse range of markets including healthcare, chemicals and fibers, housing and construction materials, and electronics. Founded in 2003, the private company has developed innovative drugs in the fields of orthopedics, acute care, neurology (including pain), and immunology. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
ASAHI KASEI CORPORATION | Process Industries |
Entreprise privées | 1 |
---|---|
Asahi Kasei Pharma Corp.
Asahi Kasei Pharma Corp. Investment ManagersFinance Part of Asahi Kasei Corp., Asahi Kasei Pharma Corp. is a pharmaceutical and diagnostic company based in Tokyo, Japan. Asahi Kasei Pharma operates in the healthcare business unit of the Asahi Kasei Group, with a mission to sincerely care for each individual life and solve their unmet medical needs with a wealth of ideas and solid science. Asahi Kasei Corp. is a US $20 billion Japanese technology company that provides innovative, science-based solutions to a diverse range of markets including healthcare, chemicals and fibers, housing and construction materials, and electronics. Founded in 2003, the private company has developed innovative drugs in the fields of orthopedics, acute care, neurology (including pain), and immunology. | Finance |